Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

7th PCNE Working Conference 2011, Manchester, United Kingdom

Does pharmaceutical care impact on the safety of individual patients?

23-26 March 2011


Does pharmaceutical care impact on the safety of individual patients?

PicTully

Dear friends, dear colleagues,

It has been our pleasure to greet many of you at theSeventh International Working Conference of Pharmaceutical Care Network Europe entitled "Does Pharmaceutical Care Impact on the Safety of Individual Patients?"

The conference has been a success, not only from a scientific viewpoint, but also socially.

PCNE strongly believes that to develop high quality research and to design or deliver effective pharmaceutical care interventions, you need to continually update yourself, exchange expertise and experience with colleagues in the same research field. This conference was developed for you to do so, whether you work in education, in industry, as a practitioner or as a researcher. You can find reports and lectures of this conference by clicking on one of the tabs above.

Dr. Mary Tully, Chairperson
Dr. Maria Cordina, Conference Secretary
 

P3240038 web

Lectures

Lecture Dr. Mikkel Nørreslet: The new consumer of pharmaceutical care services

Health care in western countries has taken a dramatic turn within the last 20-30 years. During this period of time free market mechanisms have become the guiding principle of health care policy, organization, delivery and evaluation. In the midst of change stand the patients, who are increasingly seen as someone who wants to participate in, if not control, the medical decision-making processes - as so called 'consumers'. This portrayal of patients as consumers is said to hold true, in particular, for patients who manage a chronic illness/condition, but has also been criticized for not paying sufficient attention to patients' views and experiences, among others; their perspectives on conventional medicines. The talk will discuss findings from a study that set out to explore how individuals who medically manage their own, or their child's atopic dermatitis, perceive conventional medicines and health care professionals - incl. community pharmacy staff. Study findings will be presented that nuance the portrayal of patients as consumers. The talk is aimed at persons who research, design and practice pharmaceutical services in community pharmacy.

Lecture Ms Ann Slee: Lessons on documentation of pharmaceutical care services from 'Connecting for Health'

In the changing context of healthcare - standards, quality, targets, evidence - we need to develop a coherent and consistent way of recording our activities and contributions to patient care in a way that is more transparent and creates an entry into the patient record that is visible to all.
This lecture will consider the experience of reviewing pharmacy documentation and recording in the UK as a result of the implementation of electronic patient records.

Lecture Prof. Ann Caress: Contribution of patients to the design of pharmaceutical care research

Lecture Dr. Darren Ashcroft: Changing safety culture to improve the safety of individual patients

Workshops

WS 1 How to set up a research study (a novice workshop)

Workshop facilitators:Dr. Carmel Hughes (N. Ireland) and Dr. Nina Griese (Germany)

This workshop introduced the novice researcher to the key elements of setting up intervention studies in community pharmacy practice. Formulating research questions, selection of appropriate data collection methods, pitfalls to be avoided, and consideration of the necessary research team members were explored in this workshop. The role of other types of research methodologies (e.g. qualitative methods) wasl also considered.

A PPT/PDF report of the workshop can be found here

WS2 How to develop/investigate individualised models of pharmaceutical care

Workshop facilitators: Dr. Ines Krass (Australia) and Dr. Charlotte Rossing (Denmark)

Description:This workshop commenced with presentations by workshop leaders drawing on their experiences in the development and evaluation of several pharmaceutical care programs. The presentationhighlighted the different stages in process; use of development projects and qualitative research to inform components of the intervention; selection and application of theoretical frameworks, pilot testing, implementation and design of an evaluation strategy.

In addition, the presentations will covered the formulation of relevant research questions, selection of appropriate research designs and outcome measures to answer the questions, the design of care protocols and approaches to data collection. Participants worked in two groups to identify a target population, design protocols for care delivery and a research design using both process evaluations and the principles of the ECHO model (economic, clinical and humanistic outcomes).

A PPT/PDF report of the workshop can be found here

WS3 How to measure individualised patient safety Facilitators

Workshop facilitators: Prof. Dr. Marcel Bouvy (Netherlands) and Prof. Dr. Kurt Hersberger (Switzerland)

This workshop discussed how to measure individualised patient safety, concentrating on quality indicators and the perception of safety by patients.

A PPT/PDF report of the workshop can be found here

WS4 Integrating & using multidisciplinary patient records

Workshop facilitators: Ms. Ann Slee (United Kingdom) and Dr. Veerle Foulon (Belgium)

This workshop explored the use of multidisciplinary patient records for documentation in pharmaceutical care service and research. It incudedissues such as what pharmacists should record, and differences between documentation in paper and electronic records. It resulted in a paper that oulined the requirements for a pharmaceutical care records within a general health documentation system.

A DOC/PDF report of the workshop can be found here

Posters

The role of pharmacists in the management of chronic kidney disease patients: a qualitative study

Board Number: 1

  • First Author: Salgado, Teresa(pdf file 51kb)
  • Other Authors: Moles R, Benrimoj C, Fernandez-Llimos F
  • Institute: Faculty of Pharmacy, University of Lisbon, Portugal

Designing a tool to assess completeness in drug information sources for healthcare professionals

Board Number: 2

  • First Author: Arguello, Blanca(pdf file 50kb)
  • Other Authors: Laekeman G, Fernandez-Llimos F
  • Institute: Faculty of Pharmacy, University of Lisbon, Portugal

Home medication review for patients with insulin-dependent diabetes mellitus

Board Number: 3

  • First Author: Krüger, Manfred (pdf file 49kb)
  • Other Authors: Griese N, Schulz,M
  • Institute: Linner Apotheke, Krefeld-Linn, Deutschland

Prevalence of unreached cardiometabolic targets among treated patients - subanalysis of data from a community pharmacy screening campaign in Switzerland

Board Number: 4

  • First Author: Messerli, Markus(pdf file 75kb)
  • Other Authors: Böni F, Walter P, Hersberger K
  • Institute: Pharmaceutical Care Research Group, Universität Basel, Switserland

Pharmacist-led medication review in elderly patients in Flanders: a pilot study

Board Number: 5

  • First Author: de Wulf, Isabelle(pdf file 71kb)
  • Other Authors: Depuyt C, Develter M, de Waele L, Leyssens A, Pierreux T, Vansteenkiste D, Vermaelen K, Vermeir S, Foulon V
  • Institute: Research Centre for Pharmaceutical Care and Pharmacoeconomics, Katholieke Universiteit Leuven, Belgium

Designing a tool to identify the minimum content required in a drug information source for healthcare professionals

Board Number: 6

  • First Author: Arguello, Blanca(pdf file 50kb)
  • Other Authors: Laekeman G, Fernandez-Llimos F
  • Institute: Faculty of Pharmacy, University of Lisbon, Portugal

Despite of their positive attitude, community pharmacists deliver significant less pharmaceutical care toward people with depression.

Board Number: 7

  • First Author: Liekens, Sophie(pdf file 52kb)
  • Other Authors: Smits T, Laekeman G, Foulon V
  • Institute: Research centre for pharmaceutical care and pharmaco-economics, K.U. Leuven, Belgium

Competencies, pharmaceutical care and the patient care process

Board Number: 8

  • First Author: Henman, Martin(pdf file 36kb)
  • Other Authors: Participants WS3, PCNE WC2009
  • Institute: School of pharmacy and pharmaceutical sciences, Trinity College, Dublin, Ireland

Reconciliation of medication in a trauma unit

Board Number: 9

  • First Author: Losa, Laura(pdf file 51kb)
  • Other Authors: Hidalgo E, Reig L, Girós J, Modamio P, Mariño EL
  • Institute: Hospital de Llobregat, Barcelona, Spain

Is there a higher need for pharmaceutical care for elderly patients? Incidence of potentially inadequate medication on a Urology ward

Board Number: 10

  • First Author: Heumueller, Rebekka (pdf file 67kb)
  • Other Authors: Heidenreich A, Jaehde U, Eisert A
  • Institute: Hospital Pharmacy, University Hospital, Aachen, Germany

The establishment of new cognitive services within a large collaboration of community pharmacies

Board Number: 11

  • First Author: Schwalbe, Oliver (pdf file 35kb)
  • Other Authors: Braun C, Simons S, Jaehde U
  • Institute: Abteilung Klinische Pharmazie, Pharmazeutisches Institut, Universität Bonn, Germany

How important are communication skills in pharmacy practice? Pharmacy students' perspective

Board Number: 12

  • First Author: Petríková, Alena (pdf file 53kb)
  • Other Authors: Vranová V
  • Institute: Department of Applied Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic

Antibiotic rational use – public health campaign in pharmacy environment in the Czech Republic

Board Number: 13

  • First Author: Petríková, Alena(pdf file 66kb)
  • Other Authors: Vranová V
  • Institute: Department of Applied Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic

Detection of osteoporosis risk factors in the community pharmacy setting

Board Number: 14

  • First Author: Tadic, Ivana (pdf file 49kb)
  • Other Authors: Tadic L, Lazic C
  • Institute: Dept. of Social Pharmacy and Pharmacy legislation, Faculty of Pharmacy, University of Belgrade, Serbia

Evaluation of practical pharmacy training and pharmaceutical care at the faculty of pharmacy in Brno, Czech Republic

Board Number: 15

  • First Author: Petríková, Alena(pdf file 53kb)
  • Other Authors: Vranová V, Vasut K
  • Institute: Department of Applied Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic

Do pharmacy students in Pakistan understand the concept of cancer?

Board Number: 16

  • First Author: Jamshed, Shazia Quazim(pdf file 51kb)
  • Other Authors: Obaid-ur-Rehman M, Hassali MA, Siddiqui MJA, Azhar I, Saleem F
  • Institute: Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, University Sans Malaysia, Penang, Malaysia

A short-term educational intervention to improve the understanding and perception of pharmacy students towards generic medicine

Board Number: 17

  • First Author: Jamshed, Shazia Quazim(pdf file 63kb)
  • Other Authors: Ibrahim MIM, Hassali MA, Siddiqui MJA, Obaid-ur-Rehman M
  • Institute: Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, University Sans Malaysia, Penang, Malaysia

Orals

Intensive provision of pharmaceutical care by pharmacists improves clinical outcome in migraine patients

  • First Author: Stepkova, Martina(pdf file 91kb)
  • Other Authors: Vanhecke S, Putman K, de Neve J, Verhoeven E, Leemans L, Steurbaut S, Meurs A, Saevels J, Deneyer H, Nagels F, de Wulf I, Sarre S
  • Institute: Vrije universiteit Brussel (VUB), Dept. of Pharmaceutical Chemistry, Drug Analysis and Drug Information (FASC), Brussels, Belgium

From machine to mouth: How can automated dose dispensing lead to safer and more effective patient medication?

  • First Author: Thomsen, Linda A.(pdf file 50kb)
  • Other Authors: Herborg H, Rossing C
  • Institute: Pharmakon, Hillerød, Denmark

Evaluation of pharmaceutical care activities by mystery patients during a campaign on non-prescription drugs: is there an evolution?

  • First Author: Haems, Marleen(pdf file 51kb)
  • Other Authors: Foulon V, Laekeman G
  • Institute: KOVAG, Gent, Belgium

Readability levels of patient package inserts for biopharmaceuticals

  • First Author: Piñedo-López, M.Angels(pdf file 50kb)
  • Other Authors: Modamio P, Lastra CF, Mariñi EL
  • Institute: Clinical Pharmacy and Pharmacotherapy Unit, Faculty of Pharmacy, University of Barcelona, Spain

Picturebook